|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
CA2646329C
(en)
|
2006-03-20 |
2018-07-03 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
|
WO2009032949A2
(en)
|
2007-09-04 |
2009-03-12 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
|
|
ES2712732T3
(es)
|
2009-02-17 |
2019-05-14 |
Cornell Res Foundation Inc |
Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico
|
|
AU2010325969B2
(en)
|
2009-12-02 |
2016-10-20 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen
|
|
BR112013027119A8
(pt)
*
|
2011-04-21 |
2018-03-06 |
Seattle Genetics Inc |
novos conjugados ligante-droga (adcs) e uso dos mesmos
|
|
US8679767B2
(en)
|
2011-05-12 |
2014-03-25 |
Genentech, Inc. |
Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides
|
|
CN108152513B
(zh)
*
|
2011-09-29 |
2020-07-24 |
西雅图基因公司 |
蛋白偶联的试剂化合物的整体分子量测定
|
|
KR102084805B1
(ko)
*
|
2012-03-08 |
2020-03-04 |
에프. 호프만-라 로슈 아게 |
순환 면역 복합체의 특성화를 위한 다중 크로마토그래피-면역분석 방법
|
|
CN110078827A
(zh)
|
2012-04-27 |
2019-08-02 |
西托姆克斯治疗公司 |
结合表皮生长因子受体的可活化的抗体其使用方法
|
|
WO2013180200A1
(ja)
|
2012-05-30 |
2013-12-05 |
中外製薬株式会社 |
標的組織特異的抗原結合分子
|
|
TWI693073B
(zh)
|
2012-12-21 |
2020-05-11 |
日商中外製藥股份有限公司 |
對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
|
|
EP3557260B1
(en)
|
2012-12-21 |
2022-05-18 |
Chugai Seiyaku Kabushiki Kaisha |
Gpc3-targeting drug which is administered to patient responsive to gpc3-targeting drug therapy
|
|
HK1220759A1
(zh)
|
2013-03-15 |
2017-05-12 |
Hycor Biomedical Llc |
用於进行过敏症和自身免疫性疾病的诊断测定的自动化免疫分析系统
|
|
EP2777714A1
(en)
*
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
GB2513405A
(en)
*
|
2013-04-26 |
2014-10-29 |
Adc Biotechnology Ltd |
Method of synthesising ADCs using affinity resins
|
|
US9758588B2
(en)
|
2013-09-30 |
2017-09-12 |
Becton, Dickinson And Company |
Blocking reagent compositions and methods of making and using the same
|
|
WO2015066279A2
(en)
|
2013-10-30 |
2015-05-07 |
Cytomx Therapeutics, Inc. |
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
|
|
DK3078744T3
(da)
|
2013-12-04 |
2020-09-28 |
Chugai Pharmaceutical Co Ltd |
Antigen-bindende molekyler, antigen-bindingsaktiviteten af hvilke varierer i henhold til koncentrationen af forbindelser, og biblioteker af molekylerne
|
|
WO2015089283A1
(en)
|
2013-12-11 |
2015-06-18 |
Cytomx Therapeutics, Inc. |
Antibodies that bind activatable antibodies and methods of use thereof
|
|
AU2014371934B2
(en)
|
2013-12-25 |
2020-01-23 |
Daiichi Sankyo Company, Limited |
Anti-TROP2 antibody-drug conjugate
|
|
IL310627B2
(en)
|
2014-01-31 |
2026-04-01 |
Daiichi Sankyo Co Ltd |
Anti-HER2 antibody-drug conjugates, compositions containing them and uses thereof
|
|
CN104974252B
(zh)
*
|
2014-04-01 |
2020-04-24 |
三生国健药业（上海）股份有限公司 |
一种抑制肿瘤生长的抗体-小分子药物偶联物及其制备方法和用途
|
|
EP3130608B1
(en)
|
2014-04-10 |
2019-09-04 |
Daiichi Sankyo Co., Ltd. |
(anti-her2 antibody)-drug conjugate
|
|
JP6827319B2
(ja)
|
2014-05-08 |
2021-02-10 |
中外製薬株式会社 |
Ｇｐｃ３標的治療剤療法が有効である患者に投与されるｇｐｃ３標的治療剤
|
|
MX2017005156A
(es)
*
|
2014-11-05 |
2017-08-08 |
Hoffmann La Roche |
Metodo para determinacion de anticuerpos de anti-farmaco contra anticuerpo de farmaco humano o humanizado de funcion efectora suprimida.
|
|
CN116059395A
(zh)
|
2015-06-29 |
2023-05-05 |
第一三共株式会社 |
用于选择性制造抗体-药物缀合物的方法
|
|
PL3319597T3
(pl)
|
2015-07-10 |
2021-10-11 |
Byondis B.V. |
Kompozycje zawierające koniugaty przeciwciało-duokarmycyna
|
|
US11254744B2
(en)
|
2015-08-07 |
2022-02-22 |
Imaginab, Inc. |
Antigen binding constructs to target molecules
|
|
CN106467575B
(zh)
*
|
2015-08-18 |
2020-07-31 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
US11802879B2
(en)
|
2016-03-02 |
2023-10-31 |
Waters Technologies Corporation |
Identification and quantification of conjugated peptides in antibody drug conjugates by mass spectrometry
|
|
WO2017153432A1
(en)
*
|
2016-03-07 |
2017-09-14 |
Pierre Fabre Medicament |
A new universal method to capture and analyze adcs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
|
|
US11767362B1
(en)
|
2016-03-15 |
2023-09-26 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies
|
|
CN108700598A
(zh)
*
|
2016-03-25 |
2018-10-23 |
豪夫迈·罗氏有限公司 |
多路总抗体和抗体缀合的药物量化测定法
|
|
EP3465221B1
(en)
|
2016-05-27 |
2020-07-22 |
H. Hoffnabb-La Roche Ag |
Bioanalytical method for the characterization of site-specific antibody-drug conjugates
|
|
US11273155B2
(en)
|
2016-12-12 |
2022-03-15 |
Daiichi Sankyo Company, Limited |
Combination of antibody-drug conjugate and immune checkpoint inhibitor
|
|
JP6679762B2
(ja)
|
2017-01-17 |
2020-04-15 |
第一三共株式会社 |
抗ｇｐｒ２０抗体及び抗ｇｐｒ２０抗体−薬物コンジュゲート
|
|
US11266745B2
(en)
|
2017-02-08 |
2022-03-08 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
US11092597B2
(en)
*
|
2017-02-28 |
2021-08-17 |
Waters Technoligies Corporation |
Devices and methods for analyzing intact proteins, antibodies, antibody subunits, and antibody drug conjugates
|
|
TW202532104A
(zh)
|
2017-05-15 |
2025-08-16 |
日商第一三共股份有限公司 |
抗體－藥物結合物及其用途
|
|
JP2020526584A
(ja)
|
2017-06-28 |
2020-08-31 |
ザ ロックフェラー ユニバーシティー |
抗ｍｅｒｔｋアゴニスト抗体−薬物コンジュゲートおよびその使用
|
|
CA3074208C
(en)
|
2017-08-31 |
2023-10-03 |
Daiichi Sankyo Company, Limited |
Novel method for producing antibody-drug conjugate
|
|
IL324591A
(en)
|
2017-08-31 |
2026-01-01 |
Daiichi Sankyo Co Ltd |
Improved antibody-drug conjugate production methods
|
|
CA3297825A1
(en)
*
|
2017-09-08 |
2026-03-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of assessing antibody-drug conjugates
|
|
WO2019059411A1
(en)
|
2017-09-20 |
2019-03-28 |
Chugai Seiyaku Kabushiki Kaisha |
DOSAGE FOR POLYTHERAPY USING PD-1 AXIS BINDING ANTAGONISTS AND GPC3 TARGETING AGENT
|
|
SG11202010496WA
(en)
|
2018-05-18 |
2020-12-30 |
Daiichi Sankyo Co Ltd |
Anti-muc1 antibody-drug conjugate
|
|
JP7165210B2
(ja)
|
2018-05-24 |
2022-11-02 |
シグマ－アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー |
タンパク質の定量分析
|
|
WO2020022475A1
(ja)
|
2018-07-27 |
2020-01-30 |
第一三共株式会社 |
抗体－薬物コンジュゲートの薬物部位を認識する蛋白質
|
|
CA3108044A1
(en)
|
2018-07-31 |
2020-02-06 |
Daiichi Sankyo Company, Limited |
Treatment of metastatic brain tumor by administration of antibody-drug conjugate
|
|
US12455283B2
(en)
*
|
2019-01-29 |
2025-10-28 |
Teknologian Tutkimuskeskus Vtt Oy |
Methods for screening polypeptides capable of binding specific target molecules and tools related thereto
|
|
MX2021010003A
(es)
|
2019-02-26 |
2021-12-10 |
Inspirna Inc |
Anticuerpos anti-mertk de alta afinidad y usos de los mismos.
|
|
EP3943108A4
(en)
|
2019-03-19 |
2023-01-04 |
Chugai Seiyaku Kabushiki Kaisha |
ANTIGEN-BINDING MOLECULE WITH ANTIGEN-BINDING DOMAIN WITH VARIABLE BINDING ACTIVITY TO ANTIGEN DEPENDING ON MTA AND LIBRARY TO OBTAIN THE ANTIGEN-BINDING DOMAIN
|
|
US11639938B2
(en)
*
|
2019-07-19 |
2023-05-02 |
Adeptrix Corp. |
Multiplexed bead-based analytical assays
|
|
WO2021055306A1
(en)
|
2019-09-16 |
2021-03-25 |
Bristol-Myers Squibb Company |
Dual capture method for analysis of antibody-drug conjugates
|
|
TWI886164B
(zh)
*
|
2019-10-24 |
2025-06-11 |
國立大學法人鹿兒島大學 |
1價ccap生成物之製造方法
|
|
CN111366655A
(zh)
*
|
2020-04-01 |
2020-07-03 |
上海中科新生命生物科技有限公司 |
一种基于免疫亲和的贝伐珠单抗生物分析的质谱检测方法
|
|
GB202007047D0
(en)
*
|
2020-05-13 |
2020-06-24 |
Binding Site Group Ltd |
Mass spectrometry controls
|
|
EP4229393A4
(en)
*
|
2020-10-13 |
2024-11-06 |
University of Maryland, Baltimore County |
Rapid and low-cost sampling for detection of airborne sars-cov-2 in dehumidifier condensate
|
|
WO2024108178A1
(en)
|
2022-11-18 |
2024-05-23 |
Genentech, Inc. |
Signal amplification and multiplexing using mass tags for ia-lc-ms/ms based assays
|